Article · 13 Feb 2026
Conference abstractPublished 21 Oct 2013
Good distribution practices (cGDP) and related regulatory affairs at the Brazilian supply chain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ANVISA - Health Surveillance National Agency - recently published the RDC 39 / 2013 in August 14th, which changed the administrative procedure to certify good manufacturing practices to medicine, pharmaceutical raw material, medical devices, health care and home care products. Also, it certificates storage and distribution procedures of these products. This new regulation simplifies the procedures to obtain these certifications by replacing ten other previous legislations. Ensuring these products` quality from production to dispensation in a big country with continental dimensions like Brazil is an important challenge to the current good distribution practices. This presentation will address the RDC 39/2013 certification on good distribution practices (cGDP) compared with guidelines already recognized worldwide as USP 35 / Good Storage and Shipping Practices and WHO Technical Report Series, No. 908, 2003 / Annex 9 / Guide to good storage practices for pharmaceuticals. Moreover, it will discuss the Brazilian logistic and transport scenario after the current administrative changes and the good practices used throughout the supply chain.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Frederico Rapussi”
